Methodological concerns with the meta-analysis comparing insulin degludec/liraglutide and insulin glargine/lixisenatide

被引：2
作者：
Eggert, Sarah [1 ]
Zimmermann, Esther [2 ]
Begtrup, Kamilla [3 ]
机构：
[1] Novo Nordisk AS, Global Med Affairs, Soborg, Denmark
[2] Novo Nordisk AS, Epidemiol, Soborg, Denmark
[3] Novo Nordisk AS, Biostat, Soborg, Denmark
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2018年 / 19卷 / 04期
关键词：
FIXED-RATIO COMBINATION; GLARGINE PLUS LIXISENATIDE; RANDOMIZED CLINICAL-TRIAL; LIRAGLUTIDE IDEGLIRA; EFFICACY; SAFETY; METFORMIN; LIXILAN; DEGLUDEC;
D O I：
10.1080/14656566.2018.1444882
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：317 / 318
页数：2
相关论文
共 10 条
[1]   Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial [J].
Aroda, Vanita R. ;
Rosenstock, Julio ;
Wysham, Carol ;
Unger, Jeffrey ;
Bellido, Diego ;
Gonzalez-Galvez, Guillermo ;
Takami, Akane ;
Guo, Hailing ;
Niemoeller, Elisabeth ;
Souhami, Elisabeth ;
Bergenstal, Richard M. .
DIABETES CARE, 2016, 39 (11) :1972-1980
[2]   Contribution of Liraglutide in the Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) [J].
Buse, John B. ;
Vilsboll, Tina ;
Thurman, Jerry ;
Blevins, Thomas C. ;
Langbakke, Irene H. ;
Bottcher, Susanne G. ;
Rodbard, Helena W. .
DIABETES CARE, 2014, 37 (11) :2926-2933
[3]   Comparison between insulin degludec/liraglutide treatment and insulin glargine/lixisenatide treatment in type 2 diabetes: a systematic review and meta-analysis [J].
Cai, Xiaoling ;
Gao, Xueying ;
Yang, Wenjia ;
Ji, Linong .
EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (17) :1789-1798
[4]   Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes [J].
Gough, Stephen C. L. ;
Bode, Bruce ;
Woo, Vincent ;
Rodbard, Helena W. ;
Linjawi, Sultan ;
Poulsen, Pernille ;
Damgaard, Lars H. ;
Buse, John B. .
LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (11) :885-893
[5]   Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2 [J].
Hoaglin, David C. ;
Hawkins, Neil ;
Jansen, Jeroen P. ;
Scott, David A. ;
Itzler, Robbin ;
Cappelleri, Joseph C. ;
Boersma, Cornelis ;
Thompson, David ;
Larholt, Kay M. ;
Diaz, Mireya ;
Barrett, Annabel .
VALUE IN HEALTH, 2011, 14 (04) :429-437
[6]   Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes The DUAL V Randomized Clinical Trial [J].
Lingvay, Ildiko ;
Perez Manghi, Federico ;
Garcia-Hernandez, Pedro ;
Norwood, Paul ;
Lehmann, Lucine ;
Tarp-Johansen, Mads Jeppe ;
Buse, John B. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (09) :898-907
[7]   The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial [J].
Linjawi, Sultan ;
Bode, Bruce W. ;
Chaykin, Louis B. ;
Courreges, Jean-Pierre ;
Handelsman, Yehuda ;
Lehmann, Lucine M. ;
Mishra, Abhishek ;
Simpson, Richard W. .
DIABETES THERAPY, 2017, 8 (01) :101-114
[8]   Safety and efficacy of insulin degludec/liraglutide (IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin-naive people with Type 2 diabetes: the DUAL IV trial [J].
Rodbard, H. W. ;
Bode, B. W. ;
Harris, S. B. ;
Rose, L. ;
Lehmann, L. ;
Jarlov, H. ;
Thurman, J. .
DIABETIC MEDICINE, 2017, 34 (02) :189-196
[9]   Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial [J].
Rosenstock, Julio ;
Aronson, Ronnie ;
Grunberger, George ;
Hanefeld, Markolf ;
Piatti, PierMarco ;
Serusclat, Pierre ;
Cheng, Xi ;
Zhou, Tianyue ;
Niemoeller, Elisabeth ;
Souhami, Elisabeth ;
Davies, Melanie .
DIABETES CARE, 2016, 39 (11) :2026-2035
[10]   Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial [J].
Rosenstock, Julio ;
Diamant, Michaela ;
Aroda, Vanita R. ;
Silvestre, Louise ;
Souhami, Elisabeth ;
Zhou, Tianyue ;
Perfetti, Riccardo ;
Fonseca, Vivian .
DIABETES CARE, 2016, 39 (09) :1579-1586
1